CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has recently launched its new Time-Lapse Imaging services to assist scientists in a variety of projects, including the study of cell migration in chemotaxis assays or wound healing assays, the identification of stem cells and embryos and their development, and the measurement of cell proliferation over time.
CD BioSciences has recently announced the launch of the Hyperspectral Imaging Technology to assist researchers in the detection of biological contaminants of food production at different stages.
CD BioSciences has recently announced the launch of scaffold-based technologies to assist researchers in achieving organotypic co-culture and simulating layered tissue structures.
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has recently announced the launch of label-free live cell imaging services for scientific studies, such as measuring the growth and proliferation of cells at the single-cell level and population level, and counting cells without cell staining.
CD BioSciences introduces comprehensive solutions for GPCR expression based on various strategies and technique platforms to facilitate customers’ cutting-edge programs.
CD BioSciences introduces a series of Genetic Polymorphism services for the study of GPCR polymorphisms to support customers focused on basic research and drug development process.
Satisfied Users & 
Approved Press Releases
